Literature DB >> 24857189

Plasma fibrinogen level on admission to the intensive care unit is a powerful predictor of postoperative bleeding after cardiac surgery with cardiopulmonary bypass.

Michel Kindo1, Tam Hoang Minh2, Sébastien Gerelli2, Stéphanie Perrier2, Nicolas Meyer3, Mickaël Schaeffer3, Jonathan Bentz2, Tarek Announe2, Arnaud Mommerot2, Olivier Collange4, Julien Pottecher4, Mircea Cristinar4, Jean-Claude Thiranos4, Hubert Gros4, Paul-Michel Mertes4, Philippe Billaud2, Jean-Philippe Mazzucotelli2.   

Abstract

INTRODUCTION: Evidence regarding the behavior of fibrinogen levels and the relation between fibrinogen levels and postoperative bleeding is limited in cardiac surgery under cardiopulmonary bypass (CPB). To evaluate perioperative fibrinogen levels as a predictor of postoperative bleeding in patients undergoing cardiac surgery with CPB.
MATERIALS AND METHODS: In this prospective, single-center, observational cohort study of 1956 patients following cardiac surgery with CPB, fibrinogen level was measured perioperatively. Excessive bleeding group was defined as patients with a 24-h chest tube output (CTO) exceeded the 90th percentile of distribution.
RESULTS: The median 24-h CTO was 728.6±431.1ml. A total of 189 patients (9.7%) were identified as having excessive bleeding. At admission to the intensive care (Day 0), the fibrinogen levels were 2.5±0.8g/l and 2.1±0.8g/l in the control and excessive bleeding groups, respectively (P<0.0001). The fibrinogen level on Day 0 was significantly correlated with the 24-h CTO (rho=-0.237; P<0.0001). Multivariate analysis demonstrated that the fibrinogen level at Day 0 was the best perioperative standard laboratory test to predict excessive bleeding (P=0.0001; odds ratio, 0.5), whereas preoperative fibrinogen level was not a predictor. Using receiver operating characteristics curve analyses, the best Day 0 fibrinogen level cutoff to predict postoperative bleeding was 2.2g/l.
CONCLUSIONS: In this large prospective study, the fibrinogen level upon admission to the intensive care unit after CPB predicted the risk of postoperative bleeding. Our data add to the concern regarding the fibrinogen level threshold that might require fibrinogen concentrate infusion to reduce postoperative blood loss.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiopulmonary Bypass; Coronary Disease; Fibrinogen; Heart Valve Diseases; Hemostasis, Surgical; Postoperative blood loss

Mesh:

Substances:

Year:  2014        PMID: 24857189     DOI: 10.1016/j.thromres.2014.05.008

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  5 in total

1.  Association of Plasma Fibrinogen and Thromboelastography With Blood Loss in Complex Cardiac Surgery.

Authors:  Eline A Vlot; Eric P A van Dongen; Laura M Willemsen; Jur M Ten Berg; Christian M Hackeng; Stephan A Loer; Peter G Noordzij
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

2.  Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery.

Authors:  Marco Ranucci; Ekaterina Baryshnikova; Giulia Beatrice Crapelli; Niels Rahe-Meyer; Lorenzo Menicanti; Alessandro Frigiola
Journal:  J Am Heart Assoc       Date:  2015-06-02       Impact factor: 5.501

3.  Insufficient fibrinogen response following free flap surgery is associated with bleeding complications.

Authors:  Jonas Kolbenschlag; Yannick Diehm; Adrien Daigeler; David Kampa; Sebastian Fischer; Nicolai Kapalschinski; Ole Goertz; Marcus Lehnhardt
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2016-11-22

4.  Evaluation of Plasma Fibrinogen Levels before and after Coronary Artery Bypass Graft Surgery and Its Association with the Need for Blood Products.

Authors:  Azim Honarmand; Keivan Bagheri; Alireza Hoghooghy; Kazem Rezaei
Journal:  Adv Biomed Res       Date:  2022-03-30

5.  [How I use fibrinogen replacement treatment in acquired bleeding].

Authors:  H Mei; Y Hu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2018-10-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.